Skip to main content

Military Health System

Military Health System Marks 1-Year Anniversary for COVID Vaccinations

Image of FEmale Marine gets COVID 19 vaccination in left  arm at Camp LeJeune in December 2020. Naval Medical Center Camp Lejeune on December 28, 2020, administered the first doses of the Pfizer/BioNTech COVID-19 vaccine. Per the Department of Defense’s strategic plan for distribution and administration of the vaccine, initial recipients of the vaccine were given to frontline health care providers and personnel with the Emergency Department/Trauma Department, Intensive Care Unit and other frontline workers. Vaccines also were given to frontline health care workers and first responders attached to Marine Corps Installations East to include MCAS New River, II MEF, and MARSOC.

Recommended Content:

Coronavirus & the MHS Response | COVID-19 Vaccine Efforts | COVID-19 Vaccine Efforts | Coronavirus and the COVID-19 Vaccine

One year ago today, on Dec. 14, 2020, the Military Health System began administering the first COVID-19 vaccine shots.

A year later, the MHS has distributed more than 6.4 million doses of COVID-19 vaccine and reports 90.1% of active duty service members are fully vaccinated against COVID-19, with an additional 6.4% partially vaccinated.

“The DOD is committed to vaccinating 100% of all active duty service members to ensure maximized readiness to meet the warfighter needs,” said Air Force Col. Jennifer Garrison, deputy assistant director, Operational Medicine, Defense Health Agency (DHA).

Initial vaccinations in late 2020 targeted frontline health care workers who were most at risk of exposure to the SARS-CoV-2 virus, which causes COVID-19.

Looking Back

On Dec. 9, 2020, DOD announced its COVID-19  vaccination plan.

Immediately after the Food and Drug Administration issued an emergency use authorization for the Pfizer-BioNTech messenger RNA (mRNA) vaccine on Dec. 11, 2020, the Defense Department mobilized to distribute approximately 44,000 initial doses to 13 military communities.

Among the first medical treatment facilities to receive shipments were Walter Reed National Military Medical Center in Bethesda, Maryland; Naval Medical Center San Diego, California; and the Air Force's 59th Medical Wing in San Antonio, Texas.

Those first vaccinations marked the start of a phased and coordinated plan to prioritize, distribute, and administer COVID-19 vaccines to 11.3 million DOD-eligible personnel and beneficiaries.

Military health officials later added Moderna’s two-dose COVID-19 vaccine and the Johnson & Johnson/Janssen single-dose shot to the distribution list as they received FDA emergency use authorization.

By Feb. 22, 2021, the DOD had administered 1 million doses of COVID-19 vaccines. A month later, the total grew to 2 million doses.

The Rollout Plan

To facilitate the rollout, 17 DHA Immunization Health Division (IHD) specialists stationed throughout the MHS helped military vaccine sites to become experts in COVID-19 vaccination procedures.

“The early days of the COVID-19 vaccine rollout required tremendous time and hard work. But all of us were deeply committed to getting this right,” DHA IHD specialist David Cortez said.

“Maintaining vaccine confidence in anxious patients compels us to handle and manage these vaccines absolutely correctly,” Cortez said.

Dr. Margaret Ryan, medical director for IHD in the Pacific Region, recalled that the rollout of COVID-19 vaccines in December 2020 was an intense and critical time in the pandemic. “No one in DHA IHD had a ‘holiday’ last year – but all of us celebrated in the midst of the hard work we were doing,” she said.

Later, in August 2021, as the COVID-19 Delta variant became dominant in the U.S, COVID-19 cases surged. Defense Secretary Austin issued a mandate on Aug. 24, 2021, requiring all members of the Armed Forces under DOD authority on active duty or in the Ready Reserve, including the National Guard, to receive a COVID-19 vaccination.

Keep up with the latest news about the ongoing MHS response to COVID-19 at Health.mil/coronavirus.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

Showing results 1 - 12 Page 1 of 1
Refine your search
Last Updated: September 26, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery